Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Meloxicam Market to reach USD XX billion by 2028.

Global Meloxicam Market to reach USD XX billion by 2028.

Product Code: HLSDT-29157740
Publish Date: 3-02-2022
Page: 200

Global Meloxicam Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Meloxicam is a type of drug which is used to treat the pain and inflammation in rheumatic diseases and osteoarthritis. The increasing geriatric population and developmental strategies between hospitals has led the adoption of Meloxicam across the forecast period. For Instance: as per the Statistics Netherlands’ population, in 2019 there was half the Dutch adult population was older than 50 years which will rise the meloxicam market. So, there is nearly 14 million adults and 7 million people over 50s. Also, with the rising prevalence of chronic inflammatory and pain diseases, the adoption & demand for Meloxicam is likely to increase the market growth during the forecast period. However, rising preference of NSAIDs over other pain killers impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Meloxicam market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the dominating region across the world in terms of market share owing to the presence of rising population with arthritis & other chronic pain diseases, high healthcare expenditure and research & development. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate over the forecast period 2022-2028. Factors such as increased advancement in the technology as well as growing healthcare expenditure and rising awareness program would create lucrative growth prospects for the Meloxicam market across Asia-Pacific region.

Major market player included in this report are:
Taj Pharmaceutical Limited.
Wellona Pharma
Trumac Healthcare
Healthy Life Pharma Private Limited.
EPICON LIFESCIENCES LLP
Boehringer Ingelheim GmbH.
Baudax Bio
Viatris Inc.
Avanstra Inc.
PD-Rx Pharmaceuticals, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Diseases:
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Others
By Drug Type:
Generic
Branded
By Population Type:
Adult
Children
By Dosage:
Oral
Parenteral
transdermal
Others
By Dose Strength:
7.5mg
15mg
Others
By End-Users:
Hospitals
Specialty Clinics
Home Healthcare
Others
By Distribution Channel:
Direct Tender
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Meloxicam Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Meloxicam Market, by Region, 2020-2028 (USD Billion)
1.2.2. Meloxicam Market, by Diseases, 2020-2028 (USD Billion)
1.2.3. Meloxicam Market, by Drug Type, 2020-2028 (USD Billion)
1.2.4. Meloxicam Market, by Population Type, 2020-2028 (USD Billion)
1.2.5. Meloxicam Market, by Dosage, 2020-2028 (USD Billion)
1.2.6. Meloxicam Market, by Dose Strength, 2020-2028 (USD Billion)
1.2.7. Meloxicam Market, by End-Users, 2020-2028 (USD Billion)
1.2.8. Meloxicam Market, by Distribution Channel, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Meloxicam Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Meloxicam Market Dynamics
3.1. Meloxicam Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing geriatric population
3.1.2. Market Challenges
3.1.2.1. Rising preference of NSAIDs over other pain killers
3.1.3. Market Opportunities
3.1.3.1. Rising prevalence of chronic inflammatory and pain diseases
Chapter 4. Global Meloxicam Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Meloxicam Market, by Diseases
6.1. Market Snapshot
6.2. Global Meloxicam Market by Diseases, Performance – Potential Analysis
6.3. Global Meloxicam Market Estimates & Forecasts by Diseases 2019-2028 (USD Billion)
6.4. Meloxicam Market, Sub Segment Analysis
6.4.1. Osteoarthritis
6.4.2. Rheumatoid Arthritis
6.4.3. Juvenile Rheumatoid Arthritis
6.4.4. Others
Chapter 7. Global Meloxicam Market, by Drug Type
7.1. Market Snapshot
7.2. Global Meloxicam Market by Drug Type, Performance – Potential Analysis
7.3. Global Meloxicam Market Estimates & Forecasts by Drug Type 2019-2028 (USD Billion)
7.4. Meloxicam Market, Sub Segment Analysis
7.4.1. Generic
7.4.2. Branded
Chapter 8. Global Meloxicam Market, by Population Type
8.1. Market Snapshot
8.2. Global Meloxicam Market by Population Type, Performance – Potential Analysis
8.3. Global Meloxicam Market Estimates & Forecasts by Population Type 2019-2028 (USD Billion)
8.4. Meloxicam Market, Sub Segment Analysis
8.4.1. Adult
8.4.2. Children
Chapter 9. Global Meloxicam Market, by Dosage
9.1. Market Snapshot
9.2. Global Meloxicam Market by Dosage, Performance – Potential Analysis
9.3. Global Meloxicam Market Estimates & Forecasts by Dosage 2019-2028 (USD Billion)
9.4. Meloxicam Market, Sub Segment Analysis
9.4.1. Oral
9.4.2. Parenteral
9.4.3. transdermal
9.4.4. Others
Chapter 10. Global Meloxicam Market, by Dose Strength
10.1. Market Snapshot
10.2. Global Meloxicam Market by Dose Strength, Performance – Potential Analysis
10.3. Global Meloxicam Market Estimates & Forecasts by Dose Strength2019-2028 (USD Billion)
10.4. Meloxicam Market, Sub Segment Analysis
10.4.1. 7.5mg
10.4.2. 15mg
10.4.3. Others
Chapter 11. Global Meloxicam Market, by End-Users
11.1. Market Snapshot
11.2. Global Meloxicam Market by End-Users, Performance – Potential Analysis
11.3. Global Meloxicam Market Estimates & Forecasts by End-Users2019-2028 (USD Billion)
11.4. Meloxicam Market, Sub Segment Analysis
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Home Healthcare
11.4.4. Others
Chapter 12. Global Meloxicam Market, by Distribution Channel
12.1. Market Snapshot
12.2. Global Meloxicam Market by Distribution Channel, Performance – Potential Analysis
12.3. Global Meloxicam Market Estimates & Forecasts by Distribution Channel 2019-2028 (USD Billion)
12.4. Meloxicam Market, Sub Segment Analysis
12.4.1. Direct Tender
12.4.2. Hospital Pharmacy
12.4.3. Retail Pharmacy
12.4.4. Online Pharmacy
12.4.5. Others
Chapter 13. Global Meloxicam Market, Regional Analysis
13.1. Meloxicam Market, Regional Market Snapshot
13.2. North America Meloxicam Market
13.2.1. U.S. Meloxicam Market
13.2.1.1. Diseases breakdown estimates & forecasts, 2019-2028
13.2.1.2. Drug Type breakdown estimates & forecasts, 2019-2028
13.2.1.3. Population Type breakdown estimates & forecasts, 2019-2028
13.2.1.4. Dosage breakdown estimates & forecasts, 2019-2028
13.2.1.5. Dose Strength breakdown estimates & forecasts, 2019-2028
13.2.1.6. End-Users breakdown estimates & forecasts, 2019-2028
13.2.1.7. Distribution Channel breakdown estimates & forecasts, 2019-2028
13.2.2. Canada Meloxicam Market
13.3. Europe Meloxicam Market Snapshot
13.3.1. U.K. Meloxicam Market
13.3.2. Germany Meloxicam Market
13.3.3. France Meloxicam Market
13.3.4. Spain Meloxicam Market
13.3.5. Italy Meloxicam Market
13.3.6. Rest of Europe Meloxicam Market
13.4. Asia-Pacific Meloxicam Market Snapshot
13.4.1. China Meloxicam Market
13.4.2. India Meloxicam Market
13.4.3. Japan Meloxicam Market
13.4.4. Australia Meloxicam Market
13.4.5. South Korea Meloxicam Market
13.4.6. Rest of Asia Pacific Meloxicam Market
13.5. Latin America Meloxicam Market Snapshot
13.5.1. Brazil Meloxicam Market
13.5.2. Mexico Meloxicam Market
13.6. Rest of The World Meloxicam Market

Chapter 14. Competitive Intelligence
14.1. Top Market Strategies
14.2. Company Profiles
14.2.1. Taj Pharmaceutical Limited.
14.2.1.1. Key Information
14.2.1.2. Overview
14.2.1.3. Financial (Subject to Data Availability)
14.2.1.4. Product Summary
14.2.1.5. Recent Developments
14.2.2. Wellona Pharma
14.2.3. Trumac Healthcare
14.2.4. Healthy Life Pharma Private Limited.
14.2.5. EPICON LIFESCIENCES LLP
14.2.6. Boehringer Ingelheim GmbH.
14.2.7. Baudax Bio
14.2.8. Viatris Inc.
14.2.9. Avanstra Inc.
14.2.10. PD-Rx Pharmaceuticals, Inc.
Chapter 15. Research Process
15.1. Research Process
15.1.1. Data Mining
15.1.2. Analysis
15.1.3. Market Estimation
15.1.4. Validation
15.1.5. Publishing
15.2. Research Attributes
15.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now